Information Provided By: 
Fly News Breaks for December 26, 2017
BSTC
Dec 26, 2017 | 07:10 EDT
H.C. Wainwright analyst Raghuram Selvaraju raised his 2018 earnings per share estimate for BioSpecifics Technologies to $1.93 from $1.59 after President Trump signed the new tax bill. BioSpecifics pays a small amount of New York State tax and its historical effective tax rate has been around 35%, Selvaraju tells investors in a research note. The analyst applied the new 21% effective corporate tax rate to his projections and keeps a Buy rating on BioSpecifics.
News For BSTC From the Last 2 Days
There are no results for your query BSTC
